5-[3-(Trifluoromethyl)phenyl]-2-({[3-(trifluoromethyl)phenyl]methyl}sulfanyl)pyrimidine

Catalog No. :
ACAFQB305
CAS No. :
339101-73-4
Molecular Formula :
C19H12F6N2S
Molecular Weight :
414.37

IUPAC Name:2-((3-(trifluoromethyl)benzyl)thio)-5-(3-(trifluoromethyl)phenyl)pyrimidine

5-[3-(Trifluoromethyl)phenyl]-2-({[3-(trifluoromethyl)phenyl]methyl}sulfanyl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-[3-(Trifluoromethyl)phenyl]-2-({[3-(trifluoromethyl)phenyl]methyl}sulfanyl)pyrimidine
IUPAC Name2-((3-(trifluoromethyl)benzyl)thio)-5-(3-(trifluoromethyl)phenyl)pyrimidine
MDL No.MFCD00243506
Molecular FormulaC19H12F6N2S
Molecular Weight414.37
SMILESFC(C1=CC(CSC2=NC=C(C3=CC=CC(C(F)(F)F)=C3)C=N2)=CC=C1)(F)F
InChI KeyWGMAWNFKICSGKJ-UHFFFAOYSA-N
Synonym2-([3-(TRIFLUOROMETHYL)BENZYL]SULFANYL)-5-[3-(TRIFLUOROMETHYL)PHENYL]PYRIMIDINE;3-(TRIFLUOROMETHYL)BENZYL 5-[3-(TRIFLUOROMETHYL)PHENYL]-2-PYRIMIDINYL SULFIDE;5-[3-(trifluoromethyl)phenyl]-2-({[3-(trifluoromethyl)phenyl]methyl}sulfanyl)pyrimidine;Pyrimidine, 5-[3-(trifluoromethyl)phenyl]-2-[[[3-(trifluoromethyl)phenyl]methyl]thio]-
CAS No.339101-73-4

Synthetic Route by SureRoute

1. ACAFQB305 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLPCK764 route compound structure diagram
    ACLPCK7641423-26-3 In Stock
  4. Then
  5. ACAFQB305 route product structure diagram
    ACAFQB305339101-73-4
Inquiry

2. ACAFQB305 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAFQB305 route product structure diagram
    ACAFQB305339101-73-4
Inquiry

Comments (0)